1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Immunochem Therapeutics LLC currently has 1 pending office action in its patent portfolio. This matter is assigned to 1 distinct examiner, SAHIL CHANDER AGGARWAL. As the busiest examiner for the company, SAHIL CHANDER AGGARWAL is managing the 1 pending office action currently under review. This reflects a singular point of contact for the company's active prosecution at the patent office, which can streamline the response process for the applicant.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| AGGARWAL, SAHIL CHANDER | 1 | 100.0% | +0.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18840375 | TREATMENT OF INTRACRANIAL HEMORRHAGE | AGGARWAL, SAHIL CHANDER | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18840375 | TREATMENT OF INTRACRANIAL HEMORRHAGE | AGGARWAL, SAHIL CHANDER | — | §102§103§112DPOther | Non-Final OA | — | Pending | Aug 21, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial